Takashige Abe

27PUBLICATIONS
84CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSimulation, modelling, and programming of mechatronics systemsMedicine, nursing and health curriculum and pedagogy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 14, 2026
Stage- and Age-Specific Survival According to Histological Subtype in Renal Cell Carcinoma: A Nationwide Hospital-Based Cancer Registry Analysis in Japan.

|Mar 17, 2026
A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE Study.

Shuzo Hamamoto, Masahiro Nozawa, Suguru Shirotake

|Mar 11, 2026
Current Treatment Patterns and Outcomes of Sex Cord Stromal Tumor Patients in Japan.

Takashige Abe, Kosuke Miyai, Toyonori Tsuzuki

|Nov 26, 2025
Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE Study.

Tomokazu Sazuka, Katsunori Tatsugami, Suguru Shirotake

Pageof 5